MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder...

Area of Science:

• Biochemistry
• Cancer Biology
• Immunology

Background:

• Core 2 β-1,6-N-acetylglucosaminyltransferase (C2GnT) modifies O-glycans on cell surface glycoproteins.
• C2GnT expression in bladder tumors correlates with increased metastasis and survival in circulation.
• The precise mechanisms of enhanced tumor cell survival remain to be elucidated.

Purpose of the Study:

• To investigate the role of C2GnT and core 2 O-glycans on MUC1 in bladder tumor metastasis.
• To elucidate the interaction between MUC1, galectin-3, and NK cells in the context of C2GnT expression.
• To understand how these interactions contribute to immune evasion and tumor cell survival.

Main Methods:

• Analysis of C2GnT expression in bladder tumors.
• Characterization of O-glycan structures on MUC1 in C2GnT-expressing cells.
• Investigation of galectin-3 binding to MUC1.
• Assessment of NK cell interactions with bladder tumor cells.
• Evaluation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) accessibility.

Main Results:

• C2GnT expression positively correlates with bladder tumor progression.
• Core 2 O-glycosylated MUC1 on tumor cells binds galectin-3 via poly-N-acetyllactosamine.
• Galectin-3 binding to MUC1 inhibits NK cell interaction and TRAIL accessibility.
• This MUC1-mediated mechanism facilitates immune evasion and prolonged survival of tumor cells in circulation.

Conclusions:

• MUC1 carrying core 2 O-glycans acts as a molecular shield against NK cell-mediated killing.
• This shielding effect promotes bladder tumor metastasis by enhancing survival in the bloodstream.
• Targeting this pathway could offer new therapeutic strategies for bladder cancer treatment.